WINDTREE THERAPEUTICS INC /DE/ Increase (Decrease) in Other Current Liabilities
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Increase (Decrease) in Other Current Liabilities of -$174.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2025-11-19
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was -$240.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for the quarter ending 2025-06-30 was $66.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for the quarter ending 2025-03-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for the quarter ending 2024-12-31 was -$166.00K, a 118.44% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for fiscal 2024 was -$541.00K, a 160.11% decline from fiscal 2023.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for fiscal 2023 was $900.00K.
- WINDTREE THERAPEUTICS INC /DE/ increase (decrease) in other current liabilities for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$174.00K derived: sum of 2 quarters · filed 2025-11-19 | -$174.00K 10-Q · filed 2025-11-19 | -$340.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $66.00K 10-Q · filed 2025-08-19 | -$100.00K derived: sum of 3 quarters · filed 2025-08-19 | -$300.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | -$166.00K derived: sum of 2 quarters · filed 2025-05-15 | -$366.00K derived: sum of 3 quarters · filed 2025-11-19 | -$366.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-12-31 | -$166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$366.00K derived: sum of 2 quarters · filed 2025-11-19 | -$366.00K derived: sum of 3 quarters · filed 2025-11-19 | -$541.00K 10-K · filed 2025-04-15 |
| 2024-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$200.00K derived: sum of 2 quarters · filed 2025-11-19 | -$375.00K 10-Q · filed 2025-11-19 | $525.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$175.00K 10-Q · filed 2025-08-19 | $725.00K derived: sum of 3 quarters · filed 2025-08-19 | $725.00K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | -$175.00K 10-Q · filed 2025-05-15 | $725.00K derived: sum of 2 quarters · filed 2025-05-15 | $725.00K derived: sum of 3 quarters · filed 2025-05-15 | $725.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $900.00K derived: sum of 2 quarters · filed 2025-04-15 | $900.00K derived: sum of 3 quarters · filed 2025-04-15 | $900.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-26 | $0.00 derived: sum of 2 quarters · filed 2024-11-26 | $0.00 10-Q · filed 2024-11-26 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $0.00 10-Q · filed 2024-08-19 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |